Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity. [electronic resource]
Producer: 20110203Description: 589-99 p. digitalISSN:- 1521-0103
- Animals
- Bleomycin -- administration & dosage
- Bronchi -- pathology
- Cell Line, Tumor
- Collagen -- metabolism
- Cyclic AMP -- metabolism
- Cyclic GMP -- metabolism
- Fibroblasts -- drug effects
- Goblet Cells -- pathology
- Humans
- Lung -- metabolism
- Male
- Matrix Metalloproteinase 2 -- metabolism
- Mice
- Mice, Inbred C57BL
- Monocytes -- drug effects
- Muscle, Smooth -- pathology
- Nitric Oxide -- metabolism
- Peptides -- administration & dosage
- Peroxidase -- metabolism
- Pulmonary Fibrosis -- chemically induced
- Receptors, G-Protein-Coupled -- agonists
- Receptors, Peptide -- agonists
- Relaxin -- agonists
- Signal Transduction -- drug effects
- Thiobarbituric Acid Reactive Substances -- metabolism
- Transforming Growth Factor beta1 -- pharmacology
- Tyrosine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.